{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Activated Hepatic Stellate Cells", "Corilagin", "Liver Fibrosis", "MiR-21", "Smad7", "TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31752524", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1142/S0192415X19500794"], "Journal": {"ISSN": "1793-6853", "JournalIssue": {"Volume": "47", "Issue": "7", "PubDate": {"Year": "2019"}}, "Title": "The American journal of Chinese medicine", "ISOAbbreviation": "Am J Chin Med"}, "ArticleTitle": "Inhibitory Effect of Corilagin on miR-21-Regulated Hepatic Fibrosis Signaling Pathway.", "Pagination": {"StartPage": "1541", "EndPage": "1569", "MedlinePgn": "1541-1569"}, "Abstract": {"AbstractText": ["Corilagin is a polyphenol that can be extracted from many medicinal plants and shows multiple pharmacological effects. We aimed to investigate the role of corilagin on miR-21-regulated hepatic fibrosis, especially miR-21-regulated TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1/Smad signaling pathway, in hepatic stellate LX2 cell line and Sprague-Dawley rats. The mRNA or protein levels of miR-21, Smad7, connective tissue growth factor (CTGF), <math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b1</mi></math>-smooth muscle actin (<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b1</mi></math>-SMA), tissue inhibitor of metalloproteinase-1 (TIMP-1), matrix metalloproteinase-9 (MMP-9), collagen type I alpha 1 (COL1A1), Smad2, Smad3, Smad2/3, p-Smad2, p-Smad3, p-Smad2/3, and transforming growth factor-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1 (TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1) in LX2 cells and liver tissues were determined. Furthermore, gain-of and loss-of function of miR-21 in miR-21-regulated TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1/Smad signaling pathway were analyzed in LX2 cells. Liver tissues and serum were collected for pathological analysis, immunohistochemical staining, and enzyme-linked immunosorbent assay (ELISA). Corilagin treatment reduced mRNA or protein levels of miR-21, CTGF, <math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b1</mi></math>-SMA, TIMP-1, TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1, COL1A1, p-Smad2, p-Smad3, and p-Smad2/3 both <i>in vitro</i> and <i>in vivo</i>. While corilagin increased mRNA and protein levels of Smad7 and MMP-9. After gain-of and loss-of function of miR-21, the downstream effectors of miR-21-regulated TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1/Smad signaling pathway in LX2 cells changed accordingly, and the changes were inhibited by corilagin. Simultaneously, administration of corilagin not only ameliorated pathological manifestation of liver fibrosis but also reduced levels of <math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b1</mi></math>-SMA and COL1A1 in liver tissues and TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1, ALT levels in serum. Corilagin is able to potentially prevent liver fibrosis by blocking the miR-21-regulated TGF-<math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>\u03b2</mi></math>1/Smad signaling pathway in LX2 cells and CCl<sub>4</sub>-induced liver fibrosis rats, which may provide a novel therapeutic strategy for liver fibrosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Zhou", "ForeName": "Xuan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hepatobiliary Surgery, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Xiong", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynaecology, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Lu", "ForeName": "Shi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Clinical Medicine, Hubei University of Chinese Medicine, Wuhan, P. R. China."}], "LastName": "Luo", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Chen", "ForeName": "Zhi-Lin", "Initials": "ZL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hepatology, Hubei Provincial Hospital of Chinese Medicine, Wuhan, P. R. China."}], "LastName": "Yang", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Affiliated Hospital of Jining Medical University & Shangdong Provincial Key Laboratory of Stem Cells and Neuro-Oncology, Jining, Shandong, P. R. China."}], "LastName": "Jin", "ForeName": "Feng", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Clinical Medicine, Hubei University of Chinese Medicine, Wuhan, P. R. China."}], "LastName": "Wang", "ForeName": "Yao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Hubei University, Wuhan, P. R. China."}], "LastName": "Ma", "ForeName": "Qian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Traditional and Western Medicine, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Luo", "ForeName": "Ying-Ying", "Initials": "YY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Wang", "ForeName": "Yu-Jie", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Clinical Medical, Tianjin Medical University, Tianjin 300070, P. R. China."}], "LastName": "Zhou", "ForeName": "Jia-Bin", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Clinical Medicine, Hubei University of Chinese Medicine, Wuhan, P. R. China."}], "LastName": "Liu", "ForeName": "Pan", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan 430022, P. R. China."}], "LastName": "Zhao", "ForeName": "Lei", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Am J Chin Med", "NlmUniqueID": "7901431", "ISSNLinking": "0192-415X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "COL1A1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Collagen Type I, alpha 1 Chain"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrolyzable Tannins"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Tissue Inhibitor of Metalloproteinase-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}, {"RegistryNumber": "0", "NameOfSubstance": "mirn21 microRNA, rat"}, {"RegistryNumber": "62LOS9TW6D", "NameOfSubstance": "corilagin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Collagen Type I, alpha 1 Chain"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Glucosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Hydrolyzable Tannins"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Liver"}, {"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Smad Proteins"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Tissue Inhibitor of Metalloproteinase-1"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transforming Growth Factor beta1"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "11", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31752524", "10.1142/S0192415X19500794"]}}]}